PCSK9 Inhibitor Therapeutics 2018: Analyses of Specific Patient Populations Data
An Independent Satellite CME/CE Symposium Held in Conjunction with the 2017 NLA Spring Clinical Lipid Update
This live symposium held in conjunction with the 2018 NLA Spring Clinical Update will explore and analyze data in specific patient populations in PCSK9 Inhibitor Therapeutics. Expert faculty will give updates on recent PCSK9 inhibitor data and dive into how to optimally apply these therapies into clinical practice. Recent dyslipidemia guidelines will also be reviewed. The panel will discuss how to best improve outcomes for dyslipidemia patients, including those with stroke or at high CV risk.
|2:30 – 2:35 pm:||Welcome & Introduction|
|2:35 – 2:50 pm:||Clinical Update of Recent Subset Data for Outcomes Trials Concerning PCSK9 Inhibitors|
|2:50 – 3:00 pm:||Expert Panel Analysis|
|3:00 – 3:15 pm:||Incorporate Accurate Risk Assessment, Current Guidelines and Recent PCSK9 Evidence – Based Medicine for the Prevention of CVD|
|3:15 – 3:30 pm:||Challenging Case Presentation|
This activity is designed to meet the needs of lipidologist, internists, endocrinologists, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.
At the Conclusion of this activity, participants should be able to:
- Explain the most recent subset data for outcomes trials concerning PCSK9 inhibitors.
- Apply recent dyslipidemia guidelines and optimal PCSK9 inhibitors into clinical practice.
- Incorporate recent PCSK9 inhibitor data to improve outcomes for dyslipidemia patients with stroke or at high CV risk.
- Discuss strategies to improve the knowledge, skills or performance of the healthcare team.
Hyatt Hill Country – Ballroom Hill Country A-C | 9800 Hyatt Resort Dr, San Antonio, TX 78251
Friday, February 23, 2018 Welcome & Registration: 1:00 pm – 1:30 pm CME Program: 2:30 pm – 3:30 pm
There is no fee for this educational activity.
CME credit provided by the National Lipid Association In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and AcademicCME, LLC. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Physician Credit Designation Statement The National Lipid Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity. Physician Assistants NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. Dietitians The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1 continuing professional education unit (CPEU) for completion of this program/ materials. CDR Accredited Provider #NL002.
Universal Activity Number – J0007192-9999-18-007-L01-P (Application) This Activity has been approved for 1.00 contact hour (.1 CEU) of the Accreditation Council for Pharmacy Education. Nursing The maximum number of hours awarded for this CE activity is 1.0 contact hour. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.
Criteria for Success
Statements of credit will be awarded based on the participant’s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme. For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.
Full notification of commercial support will be provided in the activity syllabus.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc.). Please contact AcdemicCME prior to the live event at firstname.lastname@example.org. This activity is jointly provided by the National Lipid Association in collaboration with AcademicCME, LLC.
CE Inquiries/Special Needs
For all CE inquiries or special needs, please contact: email@example.com or 610.687.3300.
This is an independent satellite CME/CE symposium held in conjunction with the 2018 NLA Spring Clinical Lipid Update. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee.
Alan S. Brown, MD
Director, Division of Cardiology
Advocate Lutheran General Hospital
Park Ridge, Illinois
Eliot A. Brinton, MD, FAHA, FNLA
Director, Atherometabolic Research
Utah Foundation for Biomedical Research
President, Utah Lipid Center
Salt Lake City, UT
James A. Underberg, MD, MS
Lipidology & Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
President, National Lipid Association
New York, New York
Joseph J. Saseen, PharmD, CLS, FNLA
Clinical Pharmacy and Family Medicine
University of Colorado Denver
Anschutz Medical Campus